Status:
COMPLETED
Gastrointestinal Tolerance and Safety of an Infant Formula Containing Prebiotics, Probiotics and Postbiotics.
Lead Sponsor:
Nutricia Research
Conditions:
Gastrointestinal Tolerance
Eligibility:
All Genders
14-84 years
Phase:
NA
Brief Summary
A study to investigate the gastrointestinal tolerance and safety of a new formula containing prebiotics, probiotics and postbiotics.
Eligibility Criteria
Inclusion
- Term infants with a gestational age at birth of ≥37 weeks + 0 days and ≤41 weeks + 6 days;
- Singleton, healthy infants as judged by the principle investigator;
- Infants with age at screening ≥2 weeks (14 days) and ≤ 12 weeks (84 days)
- Infants who are fully formula fed for at least 1 week prior to screening and whose parents have autonomously decided to fully formula feed, i.e. not to breastfeed or have ended breastfeeding, and who are intending to fully formula feed;
- Written informed consent from the parent(s) and/or legally acceptable representative(s), aged ≥ 18 years.
Exclusion
- Infants who require to be fed a special diet other than standard cow's milk-based infant formula;
- Infants known to have or suspected to have cow's milk protein allergy, lactose intolerance, or galactosaemia including history of any other allergic manifestations or known allergy to any of the study product ingredients;
- Infants with known or suspected congenital diseases or malformations which could interfere with the study or its outcome parameters, such as but not limited to: GI malformations, congenital metabolic disorders, severe congenital cardiac disorders, immunodeficiency or major surgery, as per the clinical judgment of the Investigator;
- Infants diagnosed with a gastrointestinal infection within 4 weeks prior to screening;
- Infants with current or previous illnesses/conditions or interventions which could interfere with the study or its outcome parameters (e.g. diarrhea requiring treatment, constipation requiring treatment, regurgitation requiring treatment, dental/medical procedures which may impact oral feeding), as per the clinical judgment of the Investigator;
- Received any of the following products/medication prior to screening: systemic antibiotics, prokinetics, proton pump inhibitors, prebiotic supplements, probiotic supplements, complementary feeding/weaning within 4 weeks prior to screening;
- Incapability of infants' parents to comply with study protocol as per the judgment of the Investigator (e.g. fluency in local language, access to laptop/smartphone devices and internet connection required for data collection);
- Infants with previous, current or intended participation in any other clinical study involving investigational or marketed products concomitantly or prior to study.
- \-
Key Trial Info
Start Date :
January 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04745455
Start Date
January 22 2021
End Date
July 12 2021
Last Update
January 25 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Poliklinika Ginekologiczno-Poloznicza Sp. Z.O.O Sp.K
Bialystok, Poland, 15-435
2
Izabela Tarczoń Przylądek Zdrowia Specjalistyczne Poradnie Medyczne
Krakow, Poland, 30-324
3
NZLA Michalkowice Jarosz i partnerzy Spolka
Siemianowice Śląskie, Poland, 41-103